 Millar M H and Modigiliani F (1961), “Dividend Policy, Growth and the

Valuation of Shares” Journal of Business, pp 441-43

 Narayanan and Barathwal, (1990) “Profitability and structure: A firm level
Study of Indian Pharmaceutical Industry” The Indian Economics Journal, vol.
38; pp.70-84
 Mehar, Ayub (2002): Corporate governance and dividend policy. Pakistan
Economic and Social Review, Vol. XLIII, pp. 115-128.
 Khan M Y and Jain P K (2007) “Financial management”, New Delhi: Tata
McGrow Hill Education Private Limited, p.30.1
 Azhagaiah, R. and Priya, N.S. (2008) The Impact of Dividend Policy on
Shareholders’ Wealth. International Research Journal of Finance and
Economics, 20, 180-187
 M Sudhahar; (2012). “Determinants of Dividend Reduction or Omission in
Indian Pharmaceutical Industry: A Logistic Regression Approach.” Regional
College of Management 12 (3), pp.201-206.
 Rambhaji, B, B (2013). “Critical analysis of dividend policy in pharmaceutical
industry a case study of selected pharmaceutical companies in Maharashtra.”
http://hdl.handle.net/10603/76998
 Reddy,C, V. (2014). “RELATIONSHIP BETWEEN DIVIDEND PAYOUT (D/P)
DECISION AND MARKET PRICE OF SHARES (MPS)-A CASE STUDY OF
SELECTED PHARMA COMPANIES IN INDIA.” International Journal of
Applied Financial Management Perspectives 3 (2).
 Thirumagal,P, G and Vasantha,S. (2016), “Dividend Policy on Shareholders
Wealth”, Indian Journal of Science and Technology Vol 9(15).
 Duru, A, N, Okpe, I, k, Evangeline, A, C; (2018). “Dividend Policy and Financial
Performance of Nigerian Pharmaceutical Firms.” IAA Journal of Applied Sciences
4(1): p.p,36-52.
 Dinesh S, Selvabaskar S, Surulivel S. T, Alamelu R, Ananthi. M; (2019). “A
Critical Analysis of Inter-Relationship between Organs of Dividend Policy in
Indian Pharmaceutical Industry.” Research J. Pharm. and Tech. 12(3):